SCHEMBL8253185

SCHEMBL8253185

BC12CCC(N)(CC1)CC2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1903771 0.78 PNMT (0.40) PNMT
Hydrochloric Acid SCHEMBL2875147 0.74 PNMT (0.38) PNMT
SCHEMBL19850684 0.67 PNMT (0.35) PNMT
SCHEMBL13944424 0.65
SCHEMBL3920707 0.61 PNMT (0.32) PNMT
SCHEMBL328889 0.61 LMNA (0.33) PNMT
SCHEMBL14344314 0.61 PNMT (0.32) PNMT
SCHEMBL13089713 0.61 PNMT (0.32) PNMT
SCHEMBL2827920 0.61 PNMT (0.32) PNMT
SCHEMBL9003691 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997109-B1 LIQUID CRYSTALLINE MEDIUM AND LIQUID CRYSTAL DEVICE MERCK PATENT GMBH (DE) 2018-03-21 EP disclosed
WO-2006128184-A2 PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS ALANTOS-PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed